Skip to main content
logo
Coegin Pharma AB (NGM:COEGIN)
Sweden flag Sweden · Delayed Price · Currency is SEK
3.010
-0.070 (-2.27%)
At close: Aug 19, 2026

Coegin Pharma AB Ratios and Metrics

Millions SEK. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
86110785197228
Market Cap Growth
14.17%40.73%55.23%-47.61%-57.65%-
Enterprise Value
84103654492197
Last Close Price
3.014.443.855.3813.4636.01

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
135.741398.18----
PB Ratio
14.2223.293.117.494.5911.35
P/TBV Ratio
19.9770.624.09-10.4611.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
131.831304.89----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Debt / Equity Ratio
-0.77-1.67-0.78-0.82-0.18-1.28
Net Debt / EBITDA Ratio
0.560.460.970.220.120.94
Net Debt / FCF Ratio
0.510.480.830.250.101.19
Asset Turnover
0.020.00----
Quick Ratio
4.450.9911.610.710.842.95
Current Ratio
5.141.1611.710.720.852.96
Return on Equity (ROE)
-124.69%-136.64%-148.58%-201.53%-171.54%-147.59%
Return on Assets (ROA)
-67.81%-63.31%-68.67%-77.82%-72.78%-68.67%
Return on Capital Employed (ROCE)
-163.50%-431.20%-92.40%-412.00%-165.10%-135.40%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-25.22%-18.56%-30.30%-55.34%-36.52%-11.91%
FCF Yield
-25.37%-15.09%-30.12%-43.58%-39.61%-9.43%
Buyback Yield / Dilution
-10.99%-31.30%-105.53%-34.42%-15.36%-354.98%